Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
| Autor: | Sang-Ho Park, Sunhyo Lee, Won-Yong Shin, Hyo-Wook Gil, Ji-Sung Lee, Eun Young Lee, Sae-Yong Hong, Jong-Oh Yang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
lcsh:Internal medicine lcsh:Specialties of internal medicine medicine.drug_class Urology medicine.medical_treatment MEDLINE Proton-pump inhibitor chemistry.chemical_element Proton pump inhibitor Gastroenterology Hypomagnesemia lcsh:RC581-951 Internal medicine Medicine In patient Magnesium skin and connective tissue diseases Diuretics lcsh:RC31-1245 business.industry Percutaneous coronary intervention medicine.disease chemistry Nephrology Original Article sense organs business Cohort study |
| Zdroj: | Kidney Research and Clinical Practice, Vol 34, Iss 2, Pp 98-102 (2015) Kidney Research and Clinical Practice |
| ISSN: | 2211-9132 |
| Popis: | Background Although cross-sectional studies have suggested a relationship between proton pump inhibitor (PPI) use and hypomagnesemia, no large-scale cohort study has been conducted to date. Here, we examined the changes in serum magnesium levels in response to PPI use. We hypothesized that PPI use might change the serum magnesium concentration. Methods Of the 2,892 patients hospitalized for percutaneous coronary intervention between January 2007 and May 2012, 1,076 patients with normal baseline (1.6–2.5 mg/dL) and follow-up serum magnesium concentrations were enrolled. These patients were divided into two groups: the PPI group and the control group. Results The mean follow-up period was 9.51 ± 2.94 months. The incidence of hypomagnesemia ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|